Zhu, Guangli
Wang, Xuan
Cao, Xinyu
Yang, Chongya
Wang, Bin
Ang, Yang
Duan, Manlin
Article History
Received: 1 August 2023
Accepted: 15 March 2024
First Online: 25 March 2024
Declarations
:
: The protocol was approved by the Study Ethics Committee of Jinling Hospital, Jinling School of Clinical Medicine, Nanjing Medical University (Ethical Approval Number: 2022DZKY-024-01 Nanjing, China) on March 18, 2022. All methods were performed in accordance with relevant guidelines and regulations and with CONSORT recommendations. The study was registered in the Chinese Clinical Trial Registry (Identifier: ChiCTR2100054089, Date: 08/12/2021). Before participation, all the patients and or their legal guardians provided written informed consent.
: Not applicable.
: The authors declare no competing interests.